Rare Nerve Fusion Explains Baffling Eye Movement Disorder in Toddler
A 2-year-old's puzzling eye paralysis pattern reveals an extraordinarily rare congenital wiring error in the oculomotor nerve.
Parkinson's disease, dopamine pathways, movement disorders, and neuroprotection
138 articles
A 2-year-old's puzzling eye paralysis pattern reveals an extraordinarily rare congenital wiring error in the oculomotor nerve.
Cambridge researchers found a gene network that shuts off nerve repair — and an existing hormone drug that reactivates it.
A newly identified proteasome activator, PA200, clears toxic alpha-synuclein aggregates and maintains function even when standard protein-disposal systems fail.
Researchers respond to critiques of their trial showing positive airway pressure therapy may improve cognitive outcomes in Parkinson's disease.
A completed RCT tests whether 6 months of moderate aerobic exercise protects memory and brain structure in older adults at genetic risk for Alzheimer's.
A professional oboist discovered that playing her instrument or singing completely suppressed her debilitating blepharospasm symptoms.
Specific AQP4 genetic variants alter glymphatic drainage efficiency, directly influencing motor symptom severity and progression in early Parkinson's disease.
A major review reveals how the glymphatic system's failure drives neurodegeneration and brain tumor resistance — and how to fix it.
New mouse study reveals how the brain's waste-clearance system modulates toxic protein buildup linked to Parkinson's disease.
New research links age at Parkinson's onset and family history to the likelihood of carrying disease-causing genetic variants.
β-endorphin released during exercise wraps around toxic Aβ aggregates, forming a 'corona' that shields brain cells from Alzheimer's damage.
From Alzheimer's to Parkinson's, a wave of novel FDA approvals is expanding treatment options for serious neurological conditions.